CD34 and Friedreich ataxia: Moreover, NKG2D-blocking experiments with either purified or nonpurified CD34+ and NK cells demonstrated that, at least in vitro, immune BM cells from patients with FA exert NKG2D-mediated inhibitory effects on the clonogenic potential of FA HSPCs, an effect that was not observed when HD BM cells were used.